Caitong International Asset Management »

Briacell Therapeutics Corp shares owned by Caitong International Asset Management

Quarter-by-quarter ownership of Briacell Therapeutics Corp (BCTX) shares owned by Caitong International Asset Management from 13F filings

Historical chart of Caitong International Asset Management investment in Briacell Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Briacell Therapeutics Corp held by Caitong International Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Briacell Therapeutics Corp by Caitong International Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $29 7 4.14

More positions owned by Caitong International Asset Management

Lumentum Hldgs (LITE)
Axt (AXTI)
Venture Global Com Cl A (VG)
Marvell Technology (MRVL)
Palantir Technologies Cl A (PLTR)
Petroleo Brasileiro S A Sponsored Adr (PBR)
Exxon Mobil Corporation (XOM)
CF Industries Holdings (CF)
Cheniere Energy Com New (LNG)
Petroleo Brasileiro S A Sp Adr Non Vtg (PBR.A)
Lam Research Corp Com New (LRCX)
Chevron Corporation (CVX)
SLB Com Stk (SLB)
Visa Com Cl A (V)
Apple (AAPL)

View all positions for Caitong International Asset Management

Top funds holding Briacell Therapeutics Corp

Cable Car Capital
Iridian Asset Management
UBS Group
Morgan Stanley
Federation des caisses Desjardins du Quebec
Royal Bank of Canada
Hanson McClain Advisors
Ssa Swiss Advisors
TD Waterhouse Canada
Group One Trading
FNY Investment Advisers
Tower Research Capital
Caitong International Asset Management
HHM Wealth Advisors
Wells Fargo & Company

View all funds holding Briacell Therapeutics Corp